Hydrocortisone supresses inflammatory activity of metalloproteinase-8 in carotid plaque
- PMID: 26313719
- PMCID: PMC4541775
- DOI: 10.5935/1678-9741.20150034
Hydrocortisone supresses inflammatory activity of metalloproteinase-8 in carotid plaque
Abstract
Objective: Matrix metalloproteinases are inflammatory biomarkers involved in carotid plaque instability. Our objective was to analyze the inflammatory activity of plasma and carotid plaque MMP-8 and MMP-9 after intravenous administration of hydrocortisone.
Methods: The study included 22 patients with stenosis ≥ 70% in the carotid artery (11 symptomatic and 11 asymptomatic) who underwent carotid endarterectomy. The patients were divided into two groups: Control Group - hydrocortisone was not administered, and Group 1 - 500 mg intravenous hydrocortisone was administered during anesthetic induction. Plasma levels of MMP-8 and MMP-9 were measured preoperatively (24 hours before carotid endarterectomy) and at 1 hour, 6 hours and 24 hours after carotid endarterectomy. In carotid plaque, tissue levels of MMP-8 and MMP-9 were measured.
Results: Group 1 showed increased serum levels of MMP- 8 (994.28 pg/ml and 408.54 pg/ml, respectively; P=0.045) and MMP-9 (106,656.34 and 42,807.69 respectively; P=0.014) at 1 hour after carotid endarterectomy compared to the control group. Symptomatic patients in Group 1 exhibited lower tissue concentration of MMP-8 in comparison to the control group (143.89 pg/ml and 1317.36 respectively; P=0.003). There was a correlation between preoperative MMP-9 levels and tissue concentrations of MMP-8 (P=0.042) and MMP-9 (P=0.019) between symptomatic patients in the control group.
Conclusion: Hydrocortisone reduces the concentration of MMP- 8 in carotid plaque, especially in symptomatic patients. There was an association between systemic and tissue inflammation.
Objetivo: As metaloproteinases são biomarcadores inflamatórios envolvidos na instabilidade da placa carotídea. O objetivo deste estudo foi analisar a atividade inflamatória da MMP-8 e MMP-9 plasmática e presente na placa carotídea, após administração intravenosa de hidrocortisona.
Métodos: Participaram do estudo 22 pacientes portadores de estenose ≥ 70% em artéria carótida (11 sintomáticos e 11 assintomáticos), submetidos à endarterectomia de artéria carótida. Os pacientes foram divididos em dois grupos: Grupo Controle - não foi administrado hidrocortisona e Grupo 1 - foi administrado 500 mg intravenoso de hidrocortisona durante a indução anestésica. As dosagens plasmáticas de MMP-8 e MMP-9 foram efetuadas no pré-operatório (24 horas antes da endarterectomia de artéria carótida) e em 1 hora, 6 horas e 24 horas após endarterectomia de artéria carótida. Na placa carotídea foram mensurados os níveis teciduais de MMP-8 e MMP-9.
Resultados: O grupo 1 exibiu elevação dos níveis séricos da MMP-8 (994,28 pg/ml e 408,54 pg/ml, respectivamente; P=0.045) e MMP-9 (106.656,34 e 42.807,69, respectivamente; P=0.014) em 1 hora após a endarterectomia de artéria carótida, em relação ao grupo controle. Os pacientes sintomáticos do grupo 1 exibiram menor concentração tecidual de MMP-8, em relação ao grupo controle (143,89 pg/ml e 1317,36, respectivamente; P=0.003). Houve correlação entre os níveis pré-operatórios de MMP-9 e as concentrações teciduais de MMP-8 (P=0.042) e MMP-9 (P=0.019) entre os pacientes sintomáticos do grupo controle.
Conclusão: A hidrocortisona reduz a concentração de MMP-8 na placa carotídea, em especial nos pacientes sintomáticos. Houve associação entre a inflamação sistêmica e a tecidual.
Figures
Similar articles
-
Markers of instability in high-risk carotid plaques are reduced by statins.J Vasc Surg. 2008 Mar;47(3):513-22. doi: 10.1016/j.jvs.2007.11.045. J Vasc Surg. 2008. PMID: 18295103
-
Analysis of the acute systemic and tissue inflammatory response following carotid endarterectomy.Int Angiol. 2016 Apr;35(2):148-56. Epub 2015 May 21. Int Angiol. 2016. PMID: 25994448
-
MMP and TIMP alterations in asymptomatic and symptomatic severe recurrent carotid artery stenosis.Eur J Vasc Endovasc Surg. 2009 May;37(5):525-30. doi: 10.1016/j.ejvs.2009.01.012. Epub 2009 Mar 17. Eur J Vasc Endovasc Surg. 2009. PMID: 19297218
-
Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression.Eur J Vasc Endovasc Surg. 2004 Jul;28(1):89-97. doi: 10.1016/j.ejvs.2004.02.022. Eur J Vasc Endovasc Surg. 2004. PMID: 15177237
-
Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis.J Vasc Surg. 2004 Sep;40(3):469-75. doi: 10.1016/j.jvs.2004.06.023. J Vasc Surg. 2004. PMID: 15337875
References
-
- Tuttolomondo A, Di Raimondo D, Pecoraro R, Arnao V, Pinto A, Licata G. Atherosclerosis as an inflammatory disease. Curr Pharm Des. 2012;18(28):4266–4288. - PubMed
-
- Hermus L, Lefrandt JD, Tio RA, Breek JC, Zeebregts CJ. Carotid plaque formation and serum biomarkers. Atherosclerosis. 2010;213(1):21–29. - PubMed
-
- Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis. 2003;169(2):203–214. - PubMed
-
- Loftus IM, Naylor R, Goodall S, Crowther M, Jones L, Bell PR, et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke. 2000;31(1):40–47. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous